Complex regulation of CDK2 and G1 arrest during neuronal differentiation of human prostatic cancer TSU-Pr1 cells by staurosporine

Anticancer Research

Volumn 21, Issue 2 A, 2001, Pages 893-898

  Shimizu, T ^a   Takahashi, N ^a   Tachibana, K ^a   Takeda, K ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Neuronal differentiation CDK2; p21; p27; Prostatic cancer; TSU Pr1

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; PROTEIN P21; PROTEIN P27; STAUROSPORINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CONTROL; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MALE; MITOSIS INHIBITION; NERVE CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION;

CDC2-CDC28 KINASES; CDC25 PHOSPHATASE; CDC42 GTP-BINDING PROTEIN; CELL DIFFERENTIATION; CYCLIN A; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; G1 PHASE; HUMANS; MALE; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; NEURONS; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; STAUROSPORINE; TUMOR CELLS, CULTURED;

EID: 0035009051     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. G1 events and regulation of cell proliferation
2. Animal cell cycles and their control
3. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins
4. Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes
5. Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A
6. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle
7. Inhibitors of mammalian G1 cyclin-dependent kinases
8. p21 is a universal inhibitor of cyclin kinases
9. WAF1, a potential mediator of p53 tumor suppression
10. The p21 Cdk- interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases
11. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
12. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
13. Cloning of p27Kip 1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
14. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution
15. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
16. CDK inhibitors: Positive and negative regulators of G1-phase progression
17. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
18. Growth suppression by p18, a p16INK4/MTS1 and p14INK4B/MTS2 related CDK6 inhibitor, correlates with wild-type pRb function
19. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6
20. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4
21. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
22. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
23. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta
24. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
25. Phorbol ester induces differentiation of a human prostatic cancer cell line TSU-Pr1 into cells with characteristics of microglia
26. Low-dose staurosporine suppresses proliferation and induces neurites in human prostatic cancer TSU-Pr1 cells
27. Establishment of a new prostatic carcinoma cell line (TSU-Pr1)
28. Complex regulation of CDKs and G1 arrest during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells
29. The kinase inhibitor staurosporine induces G1 arrest at two points: Effect on retinoblastoma protein phosphorylation and cyclin-dependent kinase 2 in normal and transformed cells
30. An important role for the retinoblastoma protein in staurosporine-induced G1 arrest in murine embryonic fibroblasts
31. Staurosporine-induced G1 arrest is associated with the induction and accumulation of cyclin-dependent kinase inhibitors
32. G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637
33. Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases
34. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
35. Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21
36. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27
37. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
38. Constitutive overexpression of CDK2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells
39. Simultaneous suppression of cdc2 and cdk2 activities induces neuronal differentiation of PC12 cells
40. The cyclin-dependent kinase inhibitor p27(Kip1) is involved in thyroid hormone-mediated neuronal differentiation
41. Expression and role of p27(kip1) in neuronal differentiation of embryonal carcinoma cells